Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA-605 (miR-605) is a small, non-coding RNA molecule that regulates gene expression post-transcriptionally, primarily by binding the 3′ untranslated regions of target mRNAs. miR-605 is transcriptionally activated by p53 and plays a pivotal role in the p53-Mdm2 feedback loop: it suppresses Mdm2, leading to increased p53 activity and robust cellular response to stress. Functionally, miR-605 inhibits cell proliferation, migration, invasion, and promotes apoptosis in various cancer models, acting as a tumor suppressor. It has shown altered expression in multiple cancers and its genetic variants or expression levels have been linked to cancer susceptibility and prognosis. No approved drugs directly target miR-605, but it is being considered as a therapeutic tool and biomarker in oncology research.
Acts as a tumor suppressor or inhibitor of oncogenicity by repressing its mRNA/protein targets (notably Mdm2, FOXP1, INPP4B, SOX9). Positive regulation of p53 by relieving p53 inhibition through Mdm2 repression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA-605 (miR-605).